| Identification | Back Directory | [Name]
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime | [CAS]
2093565-23-0 | [Synonyms]
B7183
YAP/TAZ inhibitor-1
YAP/TAZ inhibitor1,YAP/TAZ inhibitor 1
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime
9H-Fluoren-9-one, 2-[(4,4-dimethylcyclohexyl)sulfonyl]-7-[[4-(1-phenylethyl)-1-piperazinyl]sulfonyl]-, oxime | [Molecular Formula]
C33H39N3O5S2 | [MDL Number]
MFCD32062666 | [MOL File]
2093565-23-0.mol | [Molecular Weight]
621.81 |
| Chemical Properties | Back Directory | [Boiling point ]
809.4±75.0 °C(Predicted) | [density ]
1.35±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
10.06±0.20(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
2-[(4,4-Dimethylcyclohexyl)sulfonyl]-7-[[4-(1-phenylethyl)-1-piperazinyl]sulfonyl]-9H-Fluoren-9-one Oxime is used in the synthetic preparation of tricyclic heterocyclic compounds that are useful for treating cancers or congenital diseases. | [IC 50]
YAP/TAZ |
|
|